Innocon promotes Innovation at the GOED Exchange 2024 Congress in Athens


Carlos Sepúlveda, General Manager of Innocon S.A, participated in the GOED Exchange 2024 Congress, where he had the opportunity to present the range of products and services that the company provides related to Omega-3.

Innocon S.A., a leader company in innovation and development services with extensive experience in laboratory analyzes related to Omega-3, was present at the GOED Exchange 2024 Congress, held at the Grand Hyatt in Athens between January 23rd and 25th, 2024.

Carlos Sepúlveda, played an active role in the event, focusing on exploring collaboration opportunities and presenting the company’s specialized laboratory analysis services. The congress addressed crucial challenges in the Omega-3 market, such as supply chain issues and the future influence of innovative technologies such as artificial intelligence.

The participation of Innocon at this global event was significant, highlighting its commitment to the continued growth of the Omega-3 industry. The Chilean company from Coronel, took the opportunity to connect with industry colleagues, discuss relevant topics and gain key insights from thought leaders.

Sepúlveda shared his enthusiasm for the bi-annual GOED conference, highlighting both the level of presentations and the collaborative atmosphere that characterized the meeting. “For Innocon, our first participation in this Omega-3 industry conference has been extremely important. It allowed us to meet several relevant actors who, beyond business, seek to improve the health of the population through the consumption of Omega-3. Being in Athens also gave us the opportunity to directly publicize the wide range and quality of laboratory and R&D services that our company offers.”

The event addressed key topics such as artificial intelligence, customer experience, European packaging, e-commerce, sustainability, and innovative marketing strategies, and also facilitated valuable networking opportunities designed to foster new relationships and international collaborations.


Innocon reaffirms its commitment to excellence and innovation in the Omega-3 industry and hopes to continue contributing to the advancement of this area vital to the health and well-being of the global population. For more information about Innocon and its services, visit its website http://www.innocon.com.